Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid plus paclitaxel in anaplastic thyroid cancer and solid tumours
2007-005090-65Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of valproic acid and paclitaxel in anaplastic thyroid cancer (ATC) and Nonhematologic neoplasms (2 cohorts), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Survival, Tumour response and 2 more. Started Dec 2007; status: active.
02
Drugs
valproic acidpaclitaxel
03
Conditions
anaplastic thyroid cancer (ATC)Nonhematologic neoplasms
Beyond the preview
Go deeper on 2007-005090-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005090-65.